Comparative Clinical Analysis of Gastroenteropancreatic Neuroendocrine Carcinomas with Liver Metastasis and Primary Hepatic Neuroendocrine Carcinomas

Table 2

Main demographic, biochemical, and clinical characteristics of the 34 gastroenteropancreatic neuroendocrine carcinoma patients with liver metastasis.

Variable	Unit	Value
Age	Years	57.5 (33–75)
Gender	Male	20 (58.82)
ALT	U/L	20.5 (6–6012)
AST	U/L	26.5 (12–4025)
HB	G/L	126.5 (95–156)
Albumin	G/L	38.7 (20.1–47.1)
ALP	U/L	101 (48–634)
GGT	U/L	50.5 (12–1902)
CA19-9	μg/mL	15.3 (1.4–1200)
Location in liver	Left	10 (29.41)
GEP NEC diameter	cm	3.75 (1.2–15)
HbsAg	Positive	5 (14.71)
Treatment	Radical operation	17 (50)

Data are presented as the median value (range) or absolute frequency (%). GEP NECs = gastroenteropancreatic neuroendocrine carcinomas, ALT = alanine aminotransferase, AST = aspartate aminotransferase, HB = hemoglobin, ALP = alkaline phosphatase, GGT = γ-glutamyl transpeptidase, CA19-9 = carbohydrate antigen 19-9, HbsAg = hepatitis B virus surface antigen.